| |
| |
|
| Insider
Information: |
Stueland Katherine |
| Relationship: |
|
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
310,440 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,481,315 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
310,440 |
|
|
| Total
Value |
$1,481,315 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
15
|
|
Stock
price went up :
|
0
|
10
|
| Stock
price went down : |
1
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
| Percentage
Gain/Loss : |
 -66.1%
|
 3,023.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Invitae Corp |
NVTA |
Chief Commercial Officer |
2021-04-30 |
234,571 |
|
0 |
Premium* |
|
|
GeneDx Holdings Corp |
WGS |
|
2024-04-29 |
75,869 |
2022-11-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2024-04-29 |
4 |
S |
$11.04 |
$69,808 |
D/D |
(6,325) |
75,869 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2024-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,496 |
82,194 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-18 |
4 |
S |
$10.59 |
$90,661 |
D/D |
(8,559) |
66,698 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
75,257 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-12 |
4 |
S |
$9.21 |
$24,111 |
D/D |
(2,618) |
56,507 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,547 |
59,125 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-12-18 |
4 |
S |
$2.16 |
$25,338 |
D/D |
(11,734) |
52,578 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
64,312 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-12-11 |
4 |
S |
$1.61 |
$5,915 |
D/D |
(3,673) |
45,562 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,546 |
49,235 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-09-18 |
4 |
S |
$4.16 |
$44,749 |
D/D |
(10,752) |
42,689 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-09-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
53,441 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-09-11 |
4 |
S |
$4.62 |
$12,369 |
D/D |
(2,675) |
34,691 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-09-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,547 |
37,366 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-06-20 |
4 |
S |
$6.33 |
$50,727 |
D/D |
(7,965) |
30,819 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
38,784 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-06-12 |
4 |
S |
$6.49 |
$17,354 |
D/D |
(2,674) |
20,034 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,546 |
22,708 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2023-05-16 |
4 |
S |
$6.50 |
$56,439 |
D/D |
(8,685) |
16,162 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• – – |
2023-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
511,364 |
819,938 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• – – |
2023-03-10 |
4 |
S |
$0.36 |
$33,333 |
D/D |
(92,644) |
308,574 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• – – |
2023-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
216,033 |
401,218 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Chief Executive Officer |
• • – |
2022-11-28 |
4 |
B |
$0.54 |
$100,000 |
D/D |
185,185 |
185,185 |
2.81 |
% |
|
| NVTA |
Invitae Corp |
Chief Commercial Officer |
• – – |
2021-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
44,700 |
234,571 |
0 |
- |
|
| NVTA |
Invitae Corp |
Chief Commercial Officer |
• – – |
2021-04-14 |
4 |
AS |
$39.38 |
$793,209 |
D/D |
(19,893) |
189,871 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
